R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-up – 1/5/20

Proventa International Weekly News 4 years ago By Josh Neil
Proventa International Weekly News

This week, Covid-19 vaccines see some advancement, with remdesivir showing strong signs of success as Pfizer prepare to put their own candidate through U.S. trials starting from next week. In other news, ‘natural killer’ cell therapies show strong potential efficacy in fighting cancers as the next big cell therapy, and GSK announces that almost all non-Covid-related drug trials have been delayed in its search for a Covid vaccine.

PHASE 3 REMDESIVIR TRIAL SHOWS PROMISING SIGNS OF SUCCESS – Gilead’s antiviral drug Remdesivir has shortened the average recovery time for Covid-19 in the largest of several recent trials. Weak evidence also shows that the drug reduces death in patients. The U.S. director of NIAID hailed the drug as the ‘standard of care’. It allegedly reduced average time to recover by 31% over those taking a placebo. This comes as five hospitals in Australia are set to receive doses of the sought-after drug. The only confirmed hospital so far is St Vincent’s hospital in Sydney. 

PFIZER PREPARING FOR U.S. COVID-19 TRIALS NEXT WEEK – Pfizer will begin clinical trials of mRNA-based Covid candidate BNT162 in America next week, the company announced. The product has already undergone phase 1 and 2 trials in Germany, with FDA approval expected ‘shortly’. The company is expecting to manufacture millions of doses of the drug by the end of 2020.

HIGH-DOSE CHLOROQUINE TRIAL STOPPED OVER RAISED DANGER OF DEATH – A study of chloroquine, a drug similar to anti-malaria treatment hydroxychloroquine, has been stopped after high-dose patients showed a higher death rate than those who took low doses of the drug. High-dose patients also showed higher incidences of toxicity, though elements of the study meant researchers could not determine the independent toxicity of high-dose chloroquine. 

In other news: 

R&D

Natural killer cell therapies show promise for fighting cancer

Clinical Trials

GSK has delayed most of its non-Covid-19 clinical trials

UK’s ACCORD-2 pharma collaboration looks to cut Covid-19 drug development to a few weeks

AiCure releases ‘digital biomarker’ app for clinical trials

Manufacturing

AstraZeneca partners with Oxford University to produce potential vaccine

J&J and Catalent sign deal over Covid-19 vaccine manufacturing

That’s all for now. See you next week!

Joshua Neil, Editor
Proventa International

To ensure you remain up-to-date on the latest in clinical development, sign up for Proventa International’s online Clinical Operations, Supply Chain & Pharmacovigilance Strategy Meeting 2020.

More news

Role of an Immunologist: Exploring the Responsibilities

In the intricate web of human health, the immune system stands as a vigilant guardian, tirelessly defending against potential threats. At the forefront of understanding, deciphering, and harnessing the immune system's power is the immunologist. This article delves into the...

7 months ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Role of an Immunologist: Exploring the Responsibilities

In the intricate web of human health, the immune system stands as a vigilant guardian, tirelessly defending against potential threats. At the forefront of understanding, deciphering, and harnessing the immune system's power is the immunologist. This article delves into the...

7 months ago

Improving Warehouse Efficiency: The Role of Technology and Best Practices

In the fast-paced world of supply chain management, warehouse efficiency plays a pivotal role in ensuring timely and accurate order fulfillment while minimizing costs. With the rising demands of e-commerce and globalization, businesses are continually seeking innovative ways to optimize...

8 months ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Improving Warehouse Efficiency: The Role of Technology and Best Practices

In the fast-paced world of supply chain management, warehouse efficiency plays a pivotal role in ensuring timely and accurate order fulfillment while minimizing costs. With the rising demands of e-commerce and globalization, businesses are continually seeking innovative ways to optimize...

8 months ago

How to Reduce the Cost of Clinical Trial Supply Chain While Maintaining Quality and Efficiency

Clinical trial supply chain is a critical component of drug development, ensuring that drugs are available for testing, regulatory approval, and distribution. However, managing this supply chain can be challenging, with factors such as cost, quality, and efficiency all coming...

12 months ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

How to Reduce the Cost of Clinical Trial Supply Chain While Maintaining Quality and Efficiency

Clinical trial supply chain is a critical component of drug development, ensuring that drugs are available for testing, regulatory approval, and distribution. However, managing this supply chain can be challenging, with factors such as cost, quality, and efficiency all coming...

12 months ago